Genetic Sequencing Provides Hope for Expectant Families
December 3, 2024
The Walter A. and Charlotte Soule Family Foundation has long been committed to supporting newborns and expectant mothers through their generous philanthropic support of the hospital’s neonatal intensive care unit (NICU) and the Colorado Fetal Care Center (CFCC).
Their investments have positively impacted the lives of countless babies and families throughout pregnancy and beyond, along with our care team.
The Soule Family Foundation’s recent gift of $2 million has established the Walter A. and Charlotte Soule Endowed Fund to increase access to whole exome sequencing (WES) for pregnant mothers expecting babies with complex conditions. With the Soules’ investment, families can now access WES testing even if their health insurance will not cover the costs.
WES provides a detailed examination of specific parts of the baby’s genetic code, known as exons. Exons help identify any genetic changes that could impact the baby’s health, such as inherited disorders and developmental issues. This information provides vital insights for maternal and fetal care, allowing for early intervention and a highly personalized treatment plan.
The Soule Family Foundation’s generosity will continue to improve long-term health outcomes and offer more answers around complex genetic conditions, making it possible — in perpetuity — for more families to access WES every year.
